Literature DB >> 10855598

Predicting 10-year care requirements for older people with suspected Alzheimer's disease.

B P Kinosian1, E Stallard, J H Lee, M A Woodbury, A S Zbrozek, H A Glick.   

Abstract

OBJECTIVE: To describe the types and costs of care received for 10 years after the identification of an older person with suspected Alzheimer's disease (AD) by using data from 3254 patients with suspected AD who participated in the National Long Term Care Survey (NLTCS).
METHODS: By using a Markov model derived using grade of membership techniques, the following were determined: survival probabilities at 10 years; years of survival during the 10 years; years in institutions; years with two or more impairments in basic activities of daily living; hours of paid and informal care while the older person lived in the community; and costs of paid community, institutional, and medical care.
RESULTS: Greater degrees of cognitive impairment present when AD was identified were associated with reduced predicted probability of surviving 10 years, increased predicted number of years spent in institutions, increased hours of care required while affected individuals remained in the community, and increased costs of paid community, institutional, and medical care. Substantial differences between men and women were seen: severity-adjusted 10-year costs were almost two times higher for women with AD than for men ($75,000 compared with $44,000); according to sensitivity analysis, average 10-year costs might be as high as $109,000 for women and $67,000 for men.
CONCLUSIONS: AD imposes a substantial burden on older persons. Interventions that slow the progression of the disease may therefore affect community survival as well as healthcare costs.

Entities:  

Mesh:

Year:  2000        PMID: 10855598     DOI: 10.1111/j.1532-5415.2000.tb04720.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

1.  Estimation and validation of a multiattribute model of Alzheimer disease progression.

Authors:  Eric Stallard; Bruce Kinosian; Arthur S Zbrozek; Anatoliy I Yashin; Henry A Glick; Yaakov Stern
Journal:  Med Decis Making       Date:  2010 Nov-Dec       Impact factor: 2.583

2.  Development and External Validation of a Mortality Prediction Model for Community-Dwelling Older Adults With Dementia.

Authors:  W James Deardorff; Deborah E Barnes; Sun Y Jeon; W John Boscardin; Kenneth M Langa; Kenneth E Covinsky; Susan L Mitchell; Elizabeth L Whitlock; Alexander K Smith; Sei J Lee
Journal:  JAMA Intern Med       Date:  2022-09-26       Impact factor: 44.409

3.  Dementia and Medicare at life's end.

Authors:  Vicki L Lamb; Frank A Sloan; Anil S Nathan
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

4.  The Predictors study: Development and baseline characteristics of the Predictors 3 cohort.

Authors:  Yaakov Stern; Yian Gu; Stephanie Cosentino; Martina Azar; Siobhan Lawless; Oksana Tatarina
Journal:  Alzheimers Dement       Date:  2016-05-21       Impact factor: 21.566

5.  Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.

Authors:  Yaakov Stern; Eric Stallard; Bruce Kinosian; Carolyn Zhu; Stephanie Cosentino; Zhezhen Jin; Yian Gu
Journal:  Alzheimers Dement       Date:  2021-05-14       Impact factor: 21.566

6.  Personalized predictive modeling for patients with Alzheimer's disease using an extension of Sullivan's life table model.

Authors:  Eric Stallard; Bruce Kinosian; Yaakov Stern
Journal:  Alzheimers Res Ther       Date:  2017-09-20       Impact factor: 6.982

7.  Presepsis depressive symptoms are associated with incident cognitive impairment in survivors of severe sepsis: a prospective cohort study of older Americans.

Authors:  Dimitry S Davydow; Catherine L Hough; Kenneth M Langa; Theodore J Iwashyna
Journal:  J Am Geriatr Soc       Date:  2012-11-23       Impact factor: 5.562

8.  Acceptability of psychosocial interventions for dementia caregivers: a systematic review.

Authors:  Dan Qiu; Mi Hu; Yu Yu; Bingwei Tang; Shuiyuan Xiao
Journal:  BMC Psychiatry       Date:  2019-01-14       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.